V

Viridian Therapeutics

Develops miRNA-targeting therapies for autoimmune diseases

Associate Director - Modeling and Simulation

Quantitative Biology & BiostatisticsUpdated on Nov 11
Full-time

About the Job

Requirements

  • A PhD in statistics, biostatistics, or a related field with at least 6 years of relevant experience, or an MS degree with at least 10 years of relevant experience.
  • Expertise in statistical computing languages and infrastructure, including R, Python, high-performance computing, and Git.
  • Experience optimizing clinical-trial study design through simulation methods to characterize study-design performance.
  • Expertise in statistical modeling related to clinical-trial analysis and portfolio decision-making, including Bayesian modeling, joint modeling, generalized linear models, estimands, multiple comparisons, adaptive-design analysis, and benefit-risk analysis.
  • High proficiency analyzing large datasets using machine learning and large language models.
  • Ability to manage activities with competing, aggressive timelines; prioritize work; work independently; and adapt to a rapidly changing environment.
  • Demonstrated problem-solving skills, ownership in ensuring timely resolution, attention to detail, and ability to execute in a matrix environment under time and resource pressures.
  • Strong verbal and/or written communication skills.
  • Commitment to ethical standards.
  • Proficiency with Microsoft Office, including Word, PowerPoint, Excel, Outlook, and SharePoint.

Responsibilities

  • Advance the Modeling and Simulation function within Biometric Sciences by leading hands-on modeling and simulation initiatives that support quantitative decision-making across clinical development programs.
  • Develop, apply, and continuously enhance modeling approaches, including clinical-trial simulation, innovative statistical methodologies, and disease-specific models, to inform study design and portfolio strategy.
  • Drive implementation of technical capabilities, computational infrastructure, and analytical workflows that improve the efficiency, scalability, and impact of modeling and simulation activities.
  • Build, manage, and analyze a scalable, well-curated clinical-trial data repository by integrating raw and standardized datasets such as SDTM and ADaM, harmonizing metadata, and incorporating relevant external and public data sources to support advanced statistical modeling, machine-learning analyses, and cross-study research.
  • Provide analytical support to Biostatistics for evaluating and selecting study designs using simulation-based methods to maximize the probability of technical and operational success.
  • Support Clinical Development with AI solutions for efficient data review from ongoing clinical programs.
  • Conduct and support Clinical Pharmacology analyses of pharmacokinetic and pharmacodynamic data, including model-informed drug development approaches and exposure-response evaluations.
  • Generate analytical inputs and data-driven insights for Scientific Communications publication strategy, including figures, tables, and quantitative summaries for abstracts, posters, and manuscripts.
  • Collaborate with the Head of Modeling and Simulation to develop and continuously optimize biostatistical standard operating procedures and templates, enhancing efficiency and quality while meeting or exceeding industry best practices.
  • Drive organizational innovation in clinical-study design and analytical methodologies.
  • Contribute to strategic external collaborations with the biostatistics community, key opinion leaders, and external biostatistical consultants to strengthen scientific rigor and support innovation.
  • Promote collaboration and a unified focus across functions on delivering the best outcomes for patients.

About the Company

Viridian Therapeutics

Develops miRNA-targeting therapies for autoimmune diseases

Viridian Therapeutics discovers and develops therapies that target microRNA (miRNA) pathways to treat autoimmune diseases, with a focus on thyroid eye disease. The company uses monoclonal antibody technology aimed at the IGF-1 receptor (IGF-1R) pathway to modulate disease biology. Its product approach integrates miRNA biology with antibody engineering to create treatments that intervene in autoimmune processes. The company differentiates itself by combining miRNA-targeting strategies with IGF-1R–focused monoclonal antibodies, operating in the clinical-stage space and concentrating on rare thyroid-related autoimmune conditions. Its goal is to advance clinical candidates through development toward regulatory approval and eventual market launch for patients who suffer from these diseases.

Company size
201-500
Company stage
IPO
Headquarters
Waltham, MA
Founded
2007

Recently Posted Jobs

Explore more opportunities at Viridian Therapeutics

See more jobs